-Reuters
Goldman Sachs Maintains Buy on Avantor, Lowers Price Target to $32
Goldman Sachs analyst Matthew Sykes maintains Avantor (NYSE:AVTR) with a Buy and lowers the price target from $37 to $32.
Related Posts
Telsey Advisory Group Maintains Outperform on Clear Secure, Raises Price Target to $62
Telsey Advisory Group analyst Dana Telsey maintains Clear Secure (NYSE:YOU) with a Outperform and raises the price target from $50 to $62.
GW Pharmaceuticals’ Cannabidiol For Seizures Wins UK Approval
The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved GW Pharmaceuticals’ cannabidiol as an adjunctive treatment of seizures associated…
Morgan Stanley Upgrades AppLovin to Equal-Weight, Lowers Price Target to $60
Morgan Stanley analyst Brian Nowak upgrades AppLovin (NASDAQ:APP) from Underweight to Equal-Weight and lowers the price target from $68 to $60.